Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM1315MO2
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7528.091
uM
5.91580
6.44980
-0.9872 -0.2702 5.0000 0.4120
0.6082
0.9421
SUM1315MO2
TNBC
Basal B
GSK1838705A
IGF1R
RTK
10381.092
uM
inf
0.14239
0.6644 0.6861 1.9110 0.1694
0.8916
1.4137
SUM1315MO2
TNBC
Basal B
GSK1838705A
IGF1R
RTK
9044.071
uM
5.37940
7.340
-0.9986 -1.0000 3.5352 0.4850
0.9489
0.6310
SUM1315MO2
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7528.098
uM
inf
0.25981
0.6261 0.6514 1.1265 0.1323
0.9607
0.9717
SUM1315MO2
TNBC
Basal B
GSK1838705A
IGF1R
RTK
9044.091
uM
inf
0.19893
0.5371 0.5475 4.9999 0.2111
0.9825
0.6432
SUM1315MO2
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7528.071
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.5828
SUM1315MO2
TNBC
Basal B
GSK461364
PLK1
PLK
10139.001
uM
0.02135
0.02889
-0.8738 -0.5837 2.5606 0.8536
0.9771
0.7336
SUM1315MO2
TNBC
Basal B
GSK461364
PLK1
PLK
9797.001
uM
0.02360
0.02841
-0.8237 -0.7651 5.0000 1.0103
0.9859
0.6012
SUM1315MO2
TNBC
Basal B
GSK923295
CENPE
Kinesin
10139.001
uM
0.02038
0.02373
-0.2141 -0.2588 2.7392 0.7222
0.9857
0.7336
SUM1315MO2
TNBC
Basal B
GSK923295
CENPE
Kinesin
9797.001
uM
0.04247
0.04995
-0.7351 -0.6254 5.0000 0.8257
0.9905
0.6012
SUM1315MO2
TNBC
Basal B
Ibandronate
FDPS
12428.143
uM
45.03170
49.71970
-0.4598 -0.3204 5.0000 0.3279
0.9836
0.7057
SUM1315MO2
TNBC
Basal B
Ibandronate
FDPS
10875.143
uM
43.68790
48.32390
-0.4067 -0.3205 4.9112 0.3728
0.9896
0.8219
SUM1315MO2
TNBC
Basal B
ICRF-193
TOP2
TOP
10875.151
uM
0.16526
0.20236
-0.1515 -0.1151 1.0235 0.4430
0.9904
0.7096
SUM1315MO2
TNBC
Basal B
ICRF-193
TOP2
TOP
12428.157
uM
0.90538
0.48687
0.2408 0.2542 1.1444 0.2624
0.9955
0.9842
SUM1315MO2
TNBC
Basal B
IKK16
IKK
NFKB
10381.093
uM
1.79380
3.0520
-0.9893 -1.0000 2.0672 0.4814
0.9940
0.9799
SUM1315MO2
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7529.09
uM
inf
inf
-0.8193 -0.8193 0.0000 0.2798
0.5708
0.4538
SUM1315MO2
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
10381.092
uM
25.38850
37.33180
-0.9329 -0.9304 2.7262 0.3941
0.9960
1.4137
SUM1315MO2
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7528.091
uM
24.41330
33.8270
-0.9921 -0.9897 3.3475 0.4046
0.9963
0.9421
SUM1315MO2
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
9044.091
uM
22.17230
27.61230
-0.9989 -0.9977 5.0000 0.4073
0.9977
0.6432
SUM1315MO2
TNBC
Basal B
Ispinesib
KSP
Kinesin
9044.067
uM
0.01283
0.01597
-1.0000 -0.9908 4.9982 1.3236
0.7375
0.3210
SUM1315MO2
TNBC
Basal B
Ispinesib
KSP
Kinesin
7528.067
uM
0.03020
0.03608
-0.9982 -0.7162 5.0000 0.9009
0.9827
0.9386
SUM1315MO2
TNBC
Basal B
Ixabepilone
TUBB
TUBB
10381.095
uM
0.00685
0.07017
-0.9657 -0.8823 0.4369 0.8915
0.8938
1.2787
SUM1315MO2
TNBC
Basal B
Ixabepilone
TUBB
TUBB
7528.095
uM
0.01017
0.01222
-0.9950 -0.5018 3.7922 0.8979
0.9229
0.8526
SUM1315MO2
TNBC
Basal B
Ixabepilone
TUBB
TUBB
9044.095
uM
0.00170
0.00249
-0.9987 -0.6544 2.1817 1.2201
0.9538
0.7214
SUM1315MO2
TNBC
Basal B
JNK-IN-5A
JNK
JNK
12428.168
uM
1.09410
1.28580
-0.7574 -0.6212 5.0000 0.6335
0.9757
0.7957